The Effect of Trendelenburg Position on the Ultrasonographic Airway Measurements

NCT ID: NCT05224895

Last Updated: 2022-02-15

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 70 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2022-02-15
• Study Completion Date: 2022-07-30

Brief Summary

The aim of this study is to compare the changes in upper airway edema with the preoperative and postoperative ultrasonographic measurements of patients who undergo pobotic prostatectomy in the trendelenburg position.

The secondary aim is to investigate the correlation between OSAS risk levels determined by the STOP-BANG score in the preoperative period of the patients participating in the study airway ultrasound measurements and postoperative critical respiratory events in the preoperative and postoperative period.

Detailed Description

In the preoperative period, age, body weight, height, neck circumference, comorbidities (Charlson comorbidity index), ASA score, Modified mallampati classification, STOP-BANG risk score will be recorded.Intraoperative monitorization data will be recorded.

Following ultrasonographic airway measurements will be performed preoperatively and postoperatively.

A low frequency convex probe will be used for ultrasonography. To achieve a fixed position of the tongue, patients will be placed supine without a pillow, with their head fully tilted back, and asked to hold their tongue loosely, without phonation, with their mouth closed and tongue tips lightly touching the incisors. The probe will be placed under the chin in the median sagittal plane and adjusted to obtain a clear median sagittal tongue view.

Tongue thickness: When the ultrasound probe is placed under the chin on the median sagittal plane, with the mouth closed in the supine position, the tongue is in a natural position and the patient is silent, and the tongue root is displayed on the screen, the maximal vertical diameter from the tongue surface to the submental skin will be measured and recorded as tongue thickness .

Median sagittal tongue cross-sectional area: The sagittal cross-sectional area of the tongue will then be measured by tracing the circumference of the tongue on the ultrasound machine.

Tongue width: The tongue width will then be obtained by measuring the distance between the probe placed transversely under the chin and the furthest points in the middle of the tongue in order to obtain as complete a tongue contour as possible.

Tongue volume: Tongue volume will then be obtained by multiplying the mid-sagittal tongue cross-sectional area by the tongue width, as described in previous studies .

Lateral parapharyngeal wall thickness: The lateral parapharyngeal wall thickness will be measured with a linear probe placed laterally into the cervical region in the direction of the external auditory canal to visualize the branching of the carotid artery. The lateral edge of the pharynx will be visualized as a hyperechoic line. Vibration artifacts and pharyngeal position will be confirmed by swallowing the patient. The distance between the arteria carotid interna and the echogenic surface of the pharynx and the distance between the skin and the lateral wall of the pharynx will be measured .

Patients will be monitorized for critical respiratory events (CRE) postoperatively A PACU CRE is defined as, any unexpected hypoxemia (hemoglobin oxygen saturation < 90%), hypoventilation (respiratory rate < 8 bpm or arterial carbon dioxide tension > 50 mmHg), or upper airway obstruction (stridor or laryngospasm) will be considered as requiring active and specific intervention (ventilation, tracheal intubation, opioid or muscle relaxant antagonism, oral/nasal airway or airway manipulation).

1. Upper airway obstruction requiring intervention (jaw thrust, oral airway);

2. Mild to moderate hypoxemia (SpO2=93%-90%) that does not improve after active interventions in 3 L nasal cannula oxygen (increasing O2 flows to >3 L/min, high-flow surface application mask O2, verbal requests to breathe deeply, tactile stimulation);

3. Severe hypoxemia (SpO2<90%) on 3 L nasal cannula O2, hypoxemia that does not improve after treatment (increased O2 flows >3 L/min, high-flow face mask O2 application, verbal requests deep breathing, tactile stimulation);

4. Respiratory distress or signs of impending respiratory failure (respiratory rate >20/min, use of accessory muscles, tracheal tugging);

5. Inability to take deep breaths when requested by the PACU nurse;

6. The patient complains of symptoms of respiratory or upper airway muscle weakness (difficulty breathing, swallowing or speaking);

7. Patient requiring reintubation in the PACU;

8. Clinical evidence or suspected pulmonary aspiration after tracheal extubation (gastric contents and hypoxemia observed in the oropharynx)

Conditions

Airway Edema; Ultrasonography; Robotic Surgical Procedures; Postoperative Respiratory Complication

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

General Anesthesia in Trendelenburg position for robotic prostatectomy

General Anesthesia in Trendelenburg position for robotic prostatectomy

Intervention Type: PROCEDURE

in this arm, changes in preoperative and postoperative airway measurements and correlation with postoperative critical airway events will be monitored.

Interventions

General Anesthesia in Trendelenburg position for robotic prostatectomy

in this arm, changes in preoperative and postoperative airway measurements and correlation with postoperative critical airway events will be monitored.

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

1. Robotic Laparoscopic Prostatectomy

2. ASA I-II-III-IV risk group -

Exclusion Criteria

1. contraindication of trendelenburg position,

2. history of maxillofacial deformity, tumor or trauma,

3. history of difficult airway,

4. decompensated cardiac, respiratory, hepatic, renal disease,

5. with cervical spine fracture

6. patient refusal -

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: MALE
• Accepts Healthy Volunteers: No

Sponsors

Ankara City Hospital Bilkent

OTHER

Sponsor Role: lead

Responsible Party

ismail aytaç

principal investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

betül güven aytaç

Role: PRINCIPAL_INVESTIGATOR

ankara ch bilkent

Locations

Ankara City Hospital

Ankara, , Turkey (Türkiye)

Site Status: RECRUITING

Countries

Turkey (Türkiye)

Central Contacts

ismail aytac

Role: CONTACT

aytacismail1972@gmail.com

+905056340369

betül güven aytaç

Role: CONTACT

drbguven@hotmail.com

+905073578351

Facility Contacts

İsmail Aytac

Role: primary

aytacismail1972@gmail.com

+905056340369

Other Identifiers

E1-21-2231

Identifier Type: -

Identifier Source: org_study_id